Skip to content
Subscriber Only

Sinopharm Vaccine Gets WHO Backing, Facilitating Broader Use

  • China-made vaccine will add to supply for Covax global effort
  • Questions remain about efficacy compared with other shots
Video player cover image
A Race to Vaccinate the World
Updated on

China’s Sinopharm Group Co. won World Health Organization backing for its Covid-19 vaccine, paving the way for a wider rollout of the shot in countries scrambling for immunizations.

The WHO listed the vaccine for emergency use, Director General Tedros Adhanom Ghebreyesus said in a tweet on Friday. It’s recommended for adults age 18 and over.